{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:50:58Z","timestamp":1790268658673,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jpsychires.2013.10.011","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T12:08:31Z","timestamp":1382530111000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":204,"title":["Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression"],"prefix":"10.1016","volume":"48","author":[{"given":"Shadabul","family":"Haque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadab","family":"Md","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasjeet Kaur","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjula","family":"Baboota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2013.10.011_bib1","first-page":"171","article-title":"Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential","volume":"48","author":"Ahmad","year":"2006","journal-title":"The Indian Journal of Chest Diseases & Allied Sciences"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/10611860903483396","article-title":"Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses","volume":"18","author":"Al-Ghananeem","year":"2010","journal-title":"Journal of Drug Targeting"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib3","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2174\/138161210791164108","article-title":"Potential of nanoparticulate drug delivery systems by intranasal administration","volume":"10","author":"Ali","year":"2010","journal-title":"Current Pharmceutical Design"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/bdd.753","article-title":"Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine","volume":"32","author":"Bachmeier","year":"2011","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/cne.902510209","article-title":"Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey","volume":"251","author":"Balin","year":"1986","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jemermed.2005.03.007","article-title":"Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting","volume":"29","author":"Barton","year":"2005","journal-title":"The Journal of Emergency Medicine"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/cne.902420410","article-title":"Endocytic and exocytic pathways of the neuronal secretory process and trans-synaptic transfer of wheat germ agglutinin-horseradish peroxidase in\u00a0vivo","volume":"242","author":"Broadwell","year":"1985","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0810as55","article-title":"Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice","author":"Castagn\u00e9","year":"2011","journal-title":"Current Protocols in Neuroscience"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.carbpol.2005.12.010","article-title":"Monolithic gelation of chitosan solutions via enzymatic hydrolysis of urea","volume":"64","author":"Chenite","year":"2006","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","article-title":"Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment","volume":"182","author":"Cryan","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib12","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib13","unstructured":"Djupesland PG, Hafner R. Bi-directional nasal drug delivery. Innovations in Pharmaceutical Technology. www.optinose.com (accessed 18.09.13)."},{"key":"10.1016\/j.jpsychires.2013.10.011_bib58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","article-title":"Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting","volume":"47","author":"Fazil","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib14","first-page":"1237","article-title":"Tissue distribution of the multidrug resistance protein","volume":"148","author":"Flens","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib15","first-page":"429","article-title":"Development of a freeze dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration","volume":"5","author":"Fernandez-Urrusuno","year":"1999","journal-title":"STP Pharma Sciences"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib16","first-page":"5","article-title":"The burden of recurrent depression: causes, consequences and future prospects","volume":"62","author":"Greden","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib17","first-page":"83","article-title":"Comparative morphometry of the nasal cavity in rats and mice","volume":"135","author":"Gross","year":"1982","journal-title":"J\u00a0Anat"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/03639045.2011.608191","article-title":"Nanostructure based drug delivery systems for brain targeting","volume":"38","author":"Haque","year":"2012","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tips.2007.01.007","article-title":"Implications of ATP-binding cassette transporters for brain pharmacotherapies","volume":"28","author":"Hermann","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jps.20718","article-title":"Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?","volume":"96","author":"Illum","year":"2007","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/1061186021000001823","article-title":"Visualization of in\u00a0vivo olfactory uptake and transfer using fluorescein dextran","volume":"10","author":"Jansson","year":"2002","journal-title":"Journal of Drug Targeting"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10611860903386938","article-title":"Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats","volume":"18","author":"Khan","year":"2010","journal-title":"Journal of Drug Targeting"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1211\/jpp.61.05.0017","article-title":"Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats","volume":"61","author":"Khan","year":"2009","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib24","first-page":"31","article-title":"Potential new drug delivery system for antidepressants: an overview","volume":"64","author":"Kilts","year":"2003","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib25","first-page":"301","article-title":"Cognitive aspects of depression","volume":"3","author":"Kircanski","year":"2012","journal-title":"Wiley Interdisciplinary Reviews: Cognitive Science"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(81)90269-7","article-title":"Effetcs of antidepressants in rat forced swimming test","volume":"72","author":"Kitada","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","article-title":"Intranasal nanoemulsion based brain targeting drug delivery system of risperidone","volume":"358","author":"Kumar","year":"2008","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/10611860802476504","article-title":"Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting","volume":"16","author":"Kumar","year":"2008","journal-title":"Journal of Drug Targeting"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1023\/A:1011988024295","article-title":"BBB transport using MDR 1A (\u2212\/\u2212) and wild-type mice. Total brain versus microdialysis concentration profiles of Rhodamine-123","volume":"15","author":"de Lange","year":"1998","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib30","series-title":"Neuropsychopharmacology: the fifth generation of progress","first-page":"1138","article-title":"Mechanism of action of antidepressants and mood stabilizers","author":"Lenox","year":"2008"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib31","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3109\/03639041003758689","article-title":"Magnetic N-succinyl chitosan\/alginate beads for carbamazepine delivery","volume":"36","author":"Liu","year":"2010","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"Loscher","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","article-title":"Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model","volume":"48","author":"Md","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib34","first-page":"513","article-title":"Chitosan\u2013sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in\u00a0vitro characterisation","volume":"68","author":"Motwani","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future","volume":"47","author":"Muller","year":"2001","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib36","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1126\/science.274.5288.740","article-title":"Evidence-based health policy-lessons from the Global Burden of Disease Study","volume":"274","author":"Murray","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib37","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for","volume":"12","author":"Pires","year":"2009","journal-title":"Journal of Pharmacy and Pharmaceutical Sciences"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\u201cBehavioral despair\u201d in rats and mice: strain differences and the effect of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejps.2012.10.029","article-title":"Ex\u00a0vivo permeation characteristics of venlafaxine through sheep nasal mucosa","volume":"48","author":"Pund","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-3156.2008.02036.x","article-title":"The neglected \u2018m\u2019 in MCH programmes\u2013why mental health of mothers is important for child nutrition","volume":"13","author":"Rahman","year":"2008","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib42","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/jps.2600820909","article-title":"Development of a new drug carrier made from alginate","volume":"82","author":"Rajaonarivony","year":"1993","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jnnp.2004.060426","article-title":"Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke","volume":"76","author":"Rickards","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2010.11.033","article-title":"Neurotherapeutic applications of NPs in Alzheimer's disease","volume":"152","author":"Sahni","year":"2011","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2006.02.008","article-title":"Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies","volume":"66","author":"Sarmento","year":"2006","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2010.08.004","article-title":"Systemic delivery of insulin via the nasal route using a new microemulsion system: in\u00a0vitro and in\u00a0vivo studies","volume":"148","author":"Sintov","year":"2010","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib47","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.biomaterials.2004.06.020","article-title":"Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption","volume":"26","author":"Smith","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectrum"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00685714","article-title":"Metabolism and elimination of Rhodamine-123 in the rat","volume":"27","author":"Sweatman","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib50","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","article-title":"Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations","volume":"40","author":"Thorne","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.05.022","article-title":"Targeting the central nervous system: In\u00a0vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123","volume":"122","author":"Tosi","year":"2007","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib53","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/j.1552-4604.1995.tb04081.x","article-title":"The pharmacokinetics of venlafaxine when given in a twice daily regimen","volume":"35","author":"Troy","year":"1995","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.nano.2009.02.005","article-title":"Nanoparticles as drug delivery agents specific for CNS: in\u00a0vivo biodistribution","volume":"5","author":"Vergoni","year":"2009","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib55","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2010.08.020","article-title":"Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution","volume":"400","author":"Vllasaliu","year":"2010","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2131\/jts.32.97","article-title":"Venlafaxine ingestion is associated with rhabdomyolysis in adults: a case series","volume":"32","author":"Wilson","year":"2007","journal-title":"The Journal of Toxicological Sciences"},{"key":"10.1016\/j.jpsychires.2013.10.011_bib57","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijantimicag.2005.07.012","article-title":"Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis","volume":"26","author":"Zahoor","year":"2005","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395613003282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395613003282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:08:54Z","timestamp":1758366534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395613003282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0022395613003282"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2013.10.011","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2013.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}